![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
01 BUSULFAN (1)
02 CARVEDILOL (4)
03 CARVEDILOL PHOSPHATE (4)
04 CHLORAMBUCIL (1)
05 DIAZEPAM (3)
06 DUTASTERIDE (1)
07 DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE (1)
08 ESZOPICLONE (3)
09 FLUTAMIDE (1)
10 RABEPRAZOLE SODIUM (2)
11 THIOGUANINE (1)
01 WAYLIS THERAP (22)
01 CAPSULE, EXTENDED RELEASE;ORAL (4)
02 CAPSULE;ORAL (3)
03 TABLET, DELAYED RELEASE;ORAL (2)
04 TABLET;ORAL (13)
01 0.5MG (1)
02 0.5MG;0.4MG (1)
03 10MG (2)
04 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
05 12.5MG (1)
06 125MG (1)
07 1MG (1)
08 20MG (2)
09 25MG (1)
10 2MG (4)
11 3.125MG (1)
12 3MG (1)
13 40MG (2)
14 5MG (1)
15 6.25MG (1)
16 80MG (1)
01 USA (22)